Immunoradiotherapy | List of Frontiers open access articles

Original Research

Published on 03 Nov 2022

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

in Cancer Immunity and Immunotherapy

Yun Hu
Sébastien Paris
Genevieve Bertolet
Hampartsoum B. Barsoumian
Qi Wang
Jordan Da Silva
Nalini B. Patel
Nguyen Nguyen
Denaha J. Doss
Ailing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022011

6,939 views
16 citations

Original Research

Accepted on 19 Feb 2026

Artificial Intelligence–Based Prognostic Modeling of Immunoradiotherapy in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Multicenter Retrospective Study

in Pharmacology of Anti-Cancer Drugs

Yuan Li
Ying-Jie Li
Lei Yang
Su Li
Shuo Chen
Yuan-Ping Zhong
Lianbin Wen
Yanqiong Song

Frontiers in Oncology

Original Research

Published on 08 May 2025

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Gaofeng Ding
Wen Wang
Qingke Duan
Yufei Lu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1563737

2,176 views
2 citations

Mini Review

Published on 29 Jan 2026

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence

in Pharmacology of Anti-Cancer Drugs

Dongling Gu
Yi Feng
Hongyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2026.1762154

457 views

Original Research

Accepted on 17 Feb 2026

Interpretable AI for Treatment Decision-Making in Immunoradiotherapy of Locally Advanced Nasopharyngeal Carcinoma

in Pharmacology of Anti-Cancer Drugs

Guili Cao
Bin Zeng
Zifu Yuan
Xiao Hu
Hai Ou

Frontiers in Oncology

Review

Published on 17 Feb 2023

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Chen Jie
Rumeng Li
Yajie Cheng
Zhihao Wang
Qiuji Wu
Conghua Xie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1122352

7,233 views
19 citations

Original Research

Published on 20 Nov 2025

Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy

in Pharmacology of Anti-Cancer Drugs

Xiao Feng
Xiaonan Wang
Shengyuan Luo
Jianwei Zhou
Shanbao Ke

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1719479

1,268 views

Systematic Review

Published on 22 Jul 2025

Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade

in Pulmonary Medicine

Mengting Li
Peng Ding

Frontiers in Medicine

doi 10.3389/fmed.2025.1598505

2,603 views

Original Research

Published on 14 Jan 2022

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis

in Cancer Immunity and Immunotherapy

WeiWei Xiao
Yan Yuan
SuiHai Wang
Zhidong Liao
PeiQiang Cai
BaoQing Chen
Rong Zhang
Fang Wang
ZhiFan Zeng
YuanHong Gao

Frontiers in Immunology

doi 10.3389/fimmu.2021.798451

8,595 views
13 citations

Articles

NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model

Artificial Intelligence–Based Prognostic Modeling of Immunoradiotherapy in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Multicenter Retrospective Study

Neoadjuvant immunochemotherapy versus neoadjuvant immunoradiotherapy in locally advanced oral squamous cell carcinoma

Data-driven strategies for immunoradiotherapy in uveal melanoma: the role of artificial intelligence

Interpretable AI for Treatment Decision-Making in Immunoradiotherapy of Locally Advanced Nasopharyngeal Carcinoma

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer

Performance of AI-based machine learning models for overall survival prediction in advanced hepatocellular carcinoma patients receiving immunoradiotherapy

Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade

Neoadjuvant PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy in Locally Advanced Anal Canal Squamous Cell Carcinoma Patients: Antitumor Efficacy, Safety and Biomarker Analysis